AI assistant
Sending…
SELLAS Life Sciences Group, Inc. — Director's Dealing 2013
May 1, 2013
33651_dirs_2013-04-30_8d01253c-7238-4c3e-8baf-665cd6536920.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Galena Biopharma, Inc. (GALE)
CIK: 0001390478
Period of Report: 2013-04-26
Reporting Person: Ashton William (Director)
More from SELLAS Life Sciences Group, Inc.
Regulatory Filings
2026
Jun 2
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 12
Major Shareholding Notification
2026
Mar 27
Capital/Financing Update
2026
Mar 20
Major Shareholding Notification
2026
Jan 30
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9